Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses - Schedule of Accrued Expenses (Details)

v3.23.1
Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Accrued Liabilities Current [Abstract]    
External research and preclinical development $ 9,410 $ 8,219
Employee compensation and benefits 2,998 8,529
Professional fees 1,184 1,164
Facilities and other 157 54
Accrued expenses $ 13,749 $ 17,966